Melanie Grehn
Papers
2
Total Citations
42
H-Index
2
About
Melanie Grehn is a medical physicist whose work sits at the intersection of precision radiation oncology and cardiac electrophysiology. Her research focuses on stereotactic body radiotherapy (SBRT) for moving targets and the emerging field of cardiac radioablation—a non-invasive treatment for ventricular tachycardia. In her highly cited 2016 study on robotic SBRT of liver metastases, Grehn quantified the dosimetric impact of residual tracking errors, providing critical guidance for motion management in abdominal treatments. More recently, she played a central role in the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial, leading a multicenter, multiplatform benchmarking study to standardize treatment planning for cardiac radioablation. This work, published in 2022, establishes a foundation for safe and reproducible delivery of high-dose radiation to the heart. With over 40 combined citations for these two key papers, Grehn’s contributions are shaping both the technical rigor of SBRT and the clinical translation of cardiac radiosurgery. Her research is essential reading for physicists and clinicians working at the frontier of motion-managed, high-precision radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2